|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.05 USD | +1.65% |
|
-2.17% | +8.63% |
| Capitalization | 154B 133B 120B 115B 209B 14,136B 219B 1,415B 567B 6,779B 577B 565B 24,244B | P/E ratio 2026 * |
12.7x | P/E ratio 2027 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise value | 196B 169B 153B 146B 267B 18,012B 279B 1,803B 722B 8,638B 736B 720B 30,892B | EV / Sales 2026 * |
3.2x | EV / Sales 2027 * | 3.25x |
| Free-Float |
59.04% | Yield 2026 * |
6.5% | Yield 2027 * | 6.53% |
Last Transcript: Pfizer Inc.
| 1 day | +1.65% | ||
| 1 week | -2.17% | ||
| Current month | -2.17% | ||
| 1 month | -0.62% | ||
| 3 months | +3.92% | ||
| 6 months | +8.72% | ||
| Current year | +8.63% |
| 1 week | 26.2 |  | 27.61 |
| 1 month | 26.2 | | 27.94 |
| Current year | 24.83 | | 27.94 |
| 1 year | 20.92 | | 27.94 |
| 3 years | 20.92 | | 42.22 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 01/01/2019 |
David Denton
DFI | Director of Finance/CFO | 61 | 02/05/2022 |
| Chief Tech/Sci/R&D Officer | - | 24/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 01/09/2007 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 27/09/2013 |
Albert Bourla
CHM | Chairman | 64 | 01/01/2020 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.83% | 14.74% | 253 M€ | |
| -1.01% | 9.37% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.65% | -2.17% | +1.20% | -32.94% | 154B | |
| +0.72% | -5.86% | +13.89% | +218.81% | 885B | |
| +0.32% | -3.23% | +44.22% | +56.01% | 579B | |
| -0.96% | -0.85% | +7.38% | +50.47% | 407B | |
| -2.93% | -7.03% | +11.14% | +27.55% | 350B | |
| -1.25% | -5.55% | +22.14% | +55.83% | 302B | |
| -1.85% | -6.70% | +20.11% | +33.64% | 301B | |
| -0.24% | -6.49% | +22.33% | +4.06% | 286B | |
| +0.53% | -4.80% | +13.75% | +61.56% | 199B | |
| -0.83% | -3.37% | +22.59% | +79.29% | 179B | |
| Average | -0.48% | -4.40% | +17.87% | +55.43% | 364.25B | |
| Weighted average by Cap. | -0.38% | -4.47% | +19.47% | +83.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.16B 52.73B 47.6B 45.68B 83.29B 5,621B 87.17B 563B 225B 2,695B 230B 225B 9,640B | 58.93B 50.81B 45.87B 44.01B 80.25B 5,416B 83.99B 542B 217B 2,597B 221B 216B 9,289B |
| Net income | 12.06B 10.4B 9.38B 9B 16.42B 1,108B 17.18B 111B 44.44B 531B 45.25B 44.29B 1,900B | 11.66B 10.06B 9.08B 8.71B 15.88B 1,072B 16.62B 107B 42.99B 514B 43.77B 42.84B 1,838B |
| Net Debt | 42.18B 36.37B 32.83B 31.5B 57.44B 3,876B 60.11B 388B 155B 1,859B 158B 155B 6,648B | 37.95B 32.72B 29.54B 28.34B 51.68B 3,488B 54.09B 349B 140B 1,673B 142B 139B 5,982B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 27.05 $ | +1.65% | 53,181,848 |
| 05/03/26 | 26.61 $ | -0.04% | 38,908,616 |
| 04/03/26 | 26.62 $ | +0.15% | 30,893,515 |
| 03/03/26 | 26.58 $ | -2.49% | 41,486,090 |
| 02/03/26 | 27.26 $ | -1.41% | 41,321,689 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition